(Q51491057)

5 April 2018

title

Pharmacokinetics of oseltamivir in young and very elderly subjects. (English)

1 reference

5 April 2018

1 reference

1 reference

6

Craig R Rayner

1 reference

5 April 2018

author name string

Masaichi Abe

1

1 reference

5 April 2018

James Smith

2

1 reference

5 April 2018

Akinori Urae

3

1 reference

5 April 2018

Joanne Barrett

4

1 reference

5 April 2018

Haruki Kinoshita

5

1 reference

5 April 2018

language of work or name

English

0 references

publication date

29 August 2006

1 reference

5 April 2018

Annals of Pharmacotherapy

published in

1 reference

5 April 2018

volume

40

1 reference

5 April 2018

issue

10

1 reference

5 April 2018

page(s)

1724-1730

1 reference

5 April 2018

A study of the impact of influenza on the functional status of frail older people.

cites work

1 reference

Oral oseltamivir treatment of influenza in children.

21 January 2018

1 reference

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

21 January 2018

1 reference

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

21 January 2018

1 reference

Risk of pneumonia and other complications of influenza-like illness in patients treated with oseltamivir

21 January 2018

1 reference

Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.

21 January 2018

1 reference

Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza

21 January 2018

1 reference

Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population

21 January 2018

1 reference

Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis

21 January 2018

1 reference

Pharmacokinetics and dosage recommendations for an oseltamivir oral suspension for the treatment of influenza in children

21 January 2018

1 reference

Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1-5 years

21 January 2018

1 reference

The pharmacokinetics and tolerability of the oral neuraminidase inhibitor oseltamivir (Ro 64-0796/GS4104) in healthy adult and elderly volunteers.

21 January 2018

1 reference

Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802.

21 January 2018

1 reference

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

Lack of effect of moderate hepatic impairment on the pharmacokinetics of oral oseltamivir and its metabolite oseltamivir carboxylate

21 January 2018

1 reference

When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly

21 January 2018

1 reference

Creatinine clearance, Cockcroft-Gault formula and cystatin C: estimators of true glomerular filtration rate in the elderly?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1H174

1 reference

5 April 2018

1 reference

5 April 2018